InvestorsHub Logo
icon url

ziploc_1

03/27/24 9:54 AM

#422523 RE: zmanindc #422521

I assume that when China reimburses Amarin for Vascepa, followed by Amarin buying up all the API it can lay its hands on... DRL will again cry anti-trust because they will not have API for their inferior generic product.